Single-photon emission computed tomography for preclinical assessment of thyroid radioiodide uptake following various combinations of preparative measures.

Related Articles

Single-photon emission computed tomography for preclinical assessment of thyroid radioiodide uptake following various combinations of preparative measures.

Thyroid. 2016 Jun 27;

Authors: Zwarthoed C, Chatti K, Guglielmi J, Hichri M, Compin C, Darcourt J, Vassaux G, Benisvy D, Pourcher T, Cambien B

Abstract
BACKGROUND: MicroSPECT/CT imaging was used to quantitatively evaluate how iodide uptake in the mouse thyroid is influenced by i) route of iodine administration; ii) injection of recombinant human TSH (rhTSH); and iii) low iodide diet in euthyroid and T3-treated mice.
METHODS: 99mTcO4- and 123I thyroid uptake in euthyroid and T3-treated animals fed either a normal-iodine diet (NID) or a low-iodide diet (LID), treated or not with rhTSH, and radiotracer administered intravenously, subcutaneously, intraperitoneally or by gavage, were assessed using microSPECT/CT imaging. Western blotting was performed to measure Na/I symporter (NIS) expression levels in the thyroid.
RESULTS: Systemic administration of radioiodide resulted in a higher (2.35-fold in NID mice) accumulation of iodide in the thyroid than oral administration. Mice fed LID with systemic radioiodide administration showed a further two-fold increase in thyroid iodide uptake to yield a ~5-fold increase in uptake compared to the standard NID/oral route. Although rhTSH injections stimulated thyroid activity in both euthyroid and T3-treated mice fed the NID, uptake levels for T3-treated mice remained low compared with those for the euthyroid mice. Combining LID and rhTSH in T3-treated mice resulted in a 2.8-fold higher uptake compared with NID/T3/rhTSH mice and helped restore thyroid activity to levels equivalent to those of euthyroid animals.
CONCLUSIONS: Systemic radioiodide administration results in higher thyroidal iodide levels than oral administration, particularly in LID-fed mice. These data highlight the importance of LID, both in euthyroid and T3-treated, rhTSH-injected mice. Extrapolated to human patients, and in the context of clinical guidelines for the preparation of differentiated thyroid cancer patients, our data indicate that LID can potentiate the efficacy of rhTSH treatment in T3-treated patients.

PMID: 27349131 [PubMed - as supplied by publisher]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/29bQ6YU
via IFTTT